Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
NimBio is developing a noninvasive inflammometer and flarometer for use in treating chronic immune-mediated inflammatory diseases. The early detection of flare-ups on the individual patient level is based on a set of selected parameters at the subclinical stage.
NimBio’s breakthrough flare-prevention technology uses noninvasive predictive tools via wearable technology and has shown tremendous promise in a proof-of-concept clinical study.